Apogee Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Apogee Therapeutics has a total shareholder equity of $734.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $776.3M and $41.9M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$526.05m |
| Equity | US$734.40m |
| Total liabilities | US$41.88m |
| Total assets | US$776.29m |
Recent financial health updates
We're Not Very Worried About Apogee Therapeutics' (NASDAQ:APGE) Cash Burn Rate
Nov 14
We're Not Very Worried About Apogee Therapeutics' (NASDAQ:APGE) Cash Burn Rate
Jun 20We're Interested To See How Apogee Therapeutics (NASDAQ:APGE) Uses Its Cash Hoard To Grow
Mar 05We're Not Worried About Apogee Therapeutics' (NASDAQ:APGE) Cash Burn
Nov 21Recent updates
We're Not Very Worried About Apogee Therapeutics' (NASDAQ:APGE) Cash Burn Rate
Nov 14Apogee Therapeutics Earnings Preview: APG777's Potential In Atopic Dermatitis
Nov 10We're Not Very Worried About Apogee Therapeutics' (NASDAQ:APGE) Cash Burn Rate
Jun 20Apogee Therapeutics: Infrequent Dosing Advantage In Biotech Play
Jun 18We're Interested To See How Apogee Therapeutics (NASDAQ:APGE) Uses Its Cash Hoard To Grow
Mar 05Apogee Therapeutics' Innovative Leap In Atopic Dermatitis Management
Mar 05We're Not Worried About Apogee Therapeutics' (NASDAQ:APGE) Cash Burn
Nov 21Financial Position Analysis
Short Term Liabilities: APGE's short term assets ($534.5M) exceed its short term liabilities ($32.6M).
Long Term Liabilities: APGE's short term assets ($534.5M) exceed its long term liabilities ($9.3M).
Debt to Equity History and Analysis
Debt Level: APGE is debt free.
Reducing Debt: APGE has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: APGE has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: APGE has sufficient cash runway for 2.3 years if free cash flow continues to reduce at historical rates of 104.6% each year.